Z-2262-2013 Class II Terminated
FDA device recall Z-2262-2013 was initiated by Maquet Cardiovascular Us Sales, Llc on Aug 15, 2013 and is designated Class II. Reason for recall: The manufacturer has conducted a review of the results of product testing performed during the last twelve months and has identified specific lots of product which may not meet specifications for bond… The recall status is terminated (terminated Jul 11, 2017). Affected quantity: 1,182 units.
Recall details
- Product Type
- Devices
- Report Date
- Oct 2, 2013
- Initiation Date
- Aug 15, 2013
- Termination Date
- Jul 11, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,182 units
Product description
QUADROX iD HMOD 2030 Diffusion Membrane Oxygenator; QUADROX-i ADULT HMO 70000 / HMO 71000; QUADROX-iD Pediatric HMOD 30000. The QUADROX oxygenators are intended for use in extracorporeal circulation during cardiopulmonary bypass in cardiac surgery.
Reason for recall
The manufacturer has conducted a review of the results of product testing performed during the last twelve months and has identified specific lots of product which may not meet specifications for bond strength on the inlet and/or outlet connector.
Distribution pattern
Worldwide Distribution, including Nationwide (US) and foreign countries.
Code information
QUADROX-iD Adult catalog number HMOD 70000, lot # 70081567 QUADROX-i Adult catalog number VKMO 70000, lot # 70082663 QUADROX-i Adult catalog number VKMO 71000, lot # 70083974
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2262-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026